Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Xeroderma Pigmentosum 1Sebaceous Cell Tumor of Eyelid 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Longitudinal Studies × Clear all
NCT06080009 2024-02-23

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown
20 enrolled

Sebaceous Cell Tumor of Eyelid

NCT01123694 2010-05-14

Xeroderma Pigmentosum Patient Experiences

Henry Ford Health System

Unknown
15 enrolled

Xeroderma Pigmentosum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡